Pituitary somatotroph cells respond to two main stimulatory receptor systems: the GHRH receptor and the ghrelin receptor (GHS-R1a). Much GH-axis research is about how those two pathways interact, and pre-mixed blends exist so that both ligands can be supplied from one vial. This overview covers the Tesamorelin + Ipamorelin pairing. For each compound on its own, see the Tesamorelin overview and the Ipamorelin overview.
The Two Components
Tesamorelin
Tesamorelin is a synthetic analog of the full 44-amino-acid human GHRH sequence, modified at the N-terminus with a trans-3-hexenoyl group. The modification is designed to slow enzymatic cleavage at the N-terminal end, which is the main point of breakdown for native GHRH. Its molecular weight is about 5,136 Da. It acts at the GHRH receptor, a class B G-protein-coupled receptor linked to cAMP signaling.
Ipamorelin
Ipamorelin is a synthetic pentapeptide, Aib-His-D-2-Nal-D-Phe-Lys-NH2, with a molecular weight of about 712 Da. It is a growth hormone secretagogue that acts at the ghrelin receptor and is often described in the literature as selective, because early characterization studies reported little effect on other pituitary hormones compared with older GHRPs.
Why Researchers Study the Pairing
GHRH-receptor and ghrelin-receptor signaling use different intracellular routes, and preclinical studies have long examined how the two inputs combine at the somatotroph. A blend lets a lab supply both ligands in a fixed ratio (here 10mg Tesamorelin to 5mg Ipamorelin per vial). The trade-off is flexibility: a fixed ratio cannot be varied between experimental arms. For the general case, see single-compound vials vs pre-mixed blends and CJC-1295/Ipamorelin vs Tesamorelin.
Common In-Vitro Designs
- Receptor-binding and cAMP assays comparing each ligand alone with the combination.
- Pituitary cell-culture models measuring secretagogue-driven responses.
- Receptor desensitization and recovery studies with sequential or combined exposure.
- Analytical method development for separating two peptides of very different size in one sample.
Findings in receptor assays or cell models do not establish any effect in people.
What a Two-Component COA Should Report
A blend is harder to document than a single peptide. A useful certificate reports each component separately: two HPLC peaks with their own purity values, and mass spectrometry confirming both identities (about 5,136 Da and about 712 Da). Because the two molecules differ so much in size and hydrophobicity, they normally elute at well-separated retention times. A single combined purity number with no per-component breakdown is less informative. See how to read an HPLC chromatogram and reading a spec sheet and mass spectrum. Published lot certificates are listed in our COA library; confirm the compound, size and lot supplied before relying on any report.
Specifications at a Glance
- Components: Tesamorelin (GHRH analog, 44 aa) + Ipamorelin (GHS pentapeptide)
- Size: 10mg / 5mg in one vial
- Form: co-lyophilized powder
- Verification: HPLC purity and MS identity, third-party tested
Where to Go Next
View the Tesamorelin + Ipamorelin Blend 10/5mg page, the single-compound Tesamorelin and Ipamorelin pages, or browse the GH-Axis Research and Research Peptide Blends collections. Related: Sermorelin overview, CJC-1295 no DAC overview, and the pillar Researcher's Guide to Peptides in 2026.
Frequently Asked Questions
What is in a Tesamorelin + Ipamorelin blend?
One lyophilized vial containing 10mg of Tesamorelin, a modified 44-amino-acid GHRH analog, and 5mg of Ipamorelin, a ghrelin-receptor pentapeptide.
Why pair a GHRH analog with a ghrelin-receptor agonist in research?
The two ligands act at different pituitary receptors with different signaling routes, so preclinical studies examine each alone and in combination.
How do Tesamorelin and Ipamorelin differ structurally?
Tesamorelin is a 44-residue peptide of about 5,136 Da with an N-terminal trans-3-hexenoyl group. Ipamorelin is a five-residue peptide of about 712 Da containing non-natural amino acids.
What should a blend COA show?
Separate HPLC purity values for each component and mass spectrometry confirming both identities, tied to a lot number and test date that match the supplied vial.
Is this blend for human use?
No. It is sold for laboratory research use only, not for human or veterinary use, and is not intended to diagnose, treat, cure, or prevent any disease.
All products referenced in this article are sold strictly for laboratory research use only. They are not for human or veterinary use, are not drugs, foods, or cosmetics, and are not intended to diagnose, treat, cure, or prevent any disease. A Certificate of Analysis is an analytical record for a tested sample; it is research verification only and is not a statement of safety or suitability for any use outside a qualified laboratory.
